<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>19460477</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Goldsmith, D</dc:author>
<dc:description xml:lang="en">Transplantation remains the cornerstone of proper kidney disease treatments. Prevention of development or progression of chronic kidney disease, in native, or allografted, kidneys is hugely important. We review the issues around cholesterol, lipids and diabetes and therapeutic advances.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2009 May </dc:date>
<dc:title xml:lang="es">Tratamiento de la dislipemia y la diabetes mellitus en pacientes con enfermedad renal cr√≥nica. Evidencias e implicaciones.</dc:title>
<dc:title xml:lang="en">[Treating dyslipaemia in renal patients: evidences and implications].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
